(2) or End of Treatment Visitv Day 168±3 Week 28 Follow-upv Day 196±3 Informed consent Inclusion/ exclusion Demographics and baseline disease characteristics PAH medications X X X X X X Medical history Height Echocardiograme Weight at home X X X X X Dispense weight diary X X X ...